1. United States
2. N.J.
3. Letter

The recent court ruling that prevents compounding pharmacies from preparing and selling medications like Eli Lilly's Tirzepatide raises concerns about patient access and affordability. These pharmacies have provided a more cost-effective option for patients in need of life-saving drugs. Restricting their operations could force many individuals to pay exorbitant prices from major pharmaceutical companies, hindering their ability to obtain essential treatment. It is crucial to prioritize patient well-being over corporate profits by ensuring continued access to affordable medications, particularly for those with limited financial means. I urge you to consider legislative measures that safeguard the rights of compounding pharmacies to operate and serve patients in need.